Status:
WITHDRAWN
Dynamic Splinting for Excessive Pronation Following CVA
Lead Sponsor:
Dynasplint Systems, Inc.
Conditions:
Pronation Contracture
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to examine range of motion and lasting effects of Botox injections along with the use of the Supination Dynasplint.
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Patients enrolled will have been diagnosed with excessive pronation following a stroke and will display the following symptoms:
- Pronation Contracture
- Ability to provide consent and follow directions as related to the protocol
- Exclusion Criteria
- Treatment with Benzodiazepines
- Treatment with Baclofen (pump or oral)
- Treatment with Dantrolene sodium
- Treatment with Tizanidine
Exclusion
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00900692
Start Date
May 1 2009
End Date
October 1 2016
Last Update
July 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rehabilitation Associates of Indiana
Indianapolis, Indiana, United States, 46250